Among Asian patients with an average RA duration of 3.2 years, the CV risk was not significantly increased compared to TNF inhibitors [i.e., risk ratio (95% CI), 1.12 (0.64–1.95); Tong et al., 2023]. Here, TNF is linked to rheumatoid arthritis.